SCHEMBL12204203

SCHEMBL12204203

Fc1ccccc1COCCNC1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FOXM1 Q08050 2/20 0.49
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ OPRL1 P41146 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CXCR4 P61073 1/20 0.42
▸ HTR2A P28223 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ SLC6A4 P31645 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29045791 0.83 FOXM1 (0.70) FOXM1KMT2AMEN1KDM4EALDH1A1
SCHEMBL12204109 0.83 OPRL1 (0.50) FOXM1KDM4EALDH1A1OPRL1SMN1; SMN2
SCHEMBL12204774 0.83 FOXM1 (0.49) FOXM1KMT2AMEN1KDM4EALDH1A1
SCHEMBL12204763 0.82 FOXM1 (0.46) FOXM1KMT2AMEN1KDM4EALDH1A1
SCHEMBL12204207 0.79 FOXM1 (0.68) FOXM1KMT2AMEN1KDM4EALDH1A1
SCHEMBL24093122 0.77 KMT2A (0.61) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL12204305 0.77 OPRL1 (0.42) FOXM1KDM4EALDH1A1OPRL1SMN1; SMN2
Hydrochloric Acid SCHEMBL7018005 0.76 FOXM1 (0.68) FOXM1KMT2AMEN1KDM4EALDH1A1
SCHEMBL12204097 0.76 OPRL1 (0.49) FOXM1KDM4EALDH1A1OPRL1SMN1; SMN2
SCHEMBL12204080 0.74 FOXM1 (0.42) FOXM1KDM4EALDH1A1OPRL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2377856-A1 Urea glucokinase activators NOVO NORDISK A/S (DK) 2011-10-19 — — EP disclosed
Send feedback